Mirum Pharmaceuticals (MIRM) Q3 2026 Earnings Report
MX:MIRM Q3 2026 EPS Results
- Actual EPS
- ―
- Consensus EPS
- -MXN 9.05
- Beat/Miss
- ―
- One Year Ago EPS
- MXN 0.93
MX:MIRM Q3 2026 Revenue Results
- Actual Revenue
- ―
- Expected Revenue
- MXN 3.31B
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/03/2026
- Time
- After Close
- Conference Call
- Tuesday, November 3, 2026
MX:MIRM Upcoming Earnings
Mirum Pharmaceuticals's next earnings date is estimated for March 10, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:MIRM Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 10, 2027 | 2026 (Q4) | ―- | -1.86 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -9.05- | 0.93 | ― | |
| Aug 05, 2026 | 2026 (Q2) | -13.81-19.70 | -2.23 | -783.33% (-17.47) | |
| May 06, 2026 | 2026 (Q1) | -6.78-249.54 | -5.57 | -4376.67% (-243.97) | |
| Feb 25, 2026 | 2025 (Q4) | 1.04-1.86 | -9.1 | 79.59% (+7.25) | |
| Nov 04, 2025 | 2025 (Q3) | -2.600.93 | -5.57 | 116.67% (+6.50) | |
| Aug 06, 2025 | 2025 (Q2) | -6.06-2.23 | -9.66 | 76.92% (+7.43) | |
| May 07, 2025 | 2025 (Q1) | -6.13-5.57 | -10.03 | 44.44% (+4.46) | |
| Feb 26, 2025 | 2024 (Q4) | -4.79-9.10 | -11.71 | 22.22% (+2.60) | |
| Nov 12, 2024 | 2024 (Q3) | -8.34-5.57 | -10.59 | 47.37% (+5.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
